在卵巢癌中使用哨兵结核活检的未来
Nicolò Bizzarri1, Camilla Nero1,2, Stefano Di Berardino1
1UOC Ginecologia Oncologica, Dipartimento di Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS.
Current opinion in oncology
|July 17, 2024
概括
哨兵淋巴结 (SLN) 活检显示,对早期卵巢癌 (OC) 的分期有希望,具有高的检测率和准确性. 超级延迟对于识别微转移至关重要,改善了OC管理中的诊断产量.
科学领域:
- 妇科瘤学 妇科瘤学
- 手术瘤学手术瘤学
- 核医学成像技术 核医学成像技术
背景情况:
- 哨兵淋巴结 (SLN) 活检正在探索用于分期早期卵巢癌 (OC).
- 虽然淋巴切除术的诊断和预后作用已知,但其在OC中的治疗意义仍在争论中.
- SLN活检提供了一种潜在的方法来降低手术致病率.
研究的目的:
- 审查SLN活检在卵巢癌分期中的当前和未来应用.
- 评估不同标志物和注射部位在OC中检测SLN的有效性.
- 评估与OC的SLN活检相关的诊断准确性和并发症率.
主要方法:
- 关于SLN活检技术和卵巢癌的结果的最新证据的审查.
- 基于标记物类型 (印ocyanine绿色,技术,蓝色染料) 和注射部位 (卵巢带,子宫) 的SLN检测率的分析.
- 评估SLN的灵敏度,准确度和并发症率,包括超级延迟的作用.
主要成果:
- 结合的标记物 (ICG + 技术) 产生了最高的SLN检测率 (95%).
- 根据注射部位和标记物,SLN检测率有很大的差异,报告了高灵敏度 (73.3-100%) 和准确性 (96-100%).
- 在高达40%的阳性SLN中,超级延迟检测发现了微转移,否则可能会错过.
结论:
- 哨兵淋巴结活检是评估明显早期卵巢癌中淋巴结状况的有希望的工具.
- 标记物类型,体积和注射部位影响SLN检测率.
- 超级延缓协议对于检测低体积转移至关重要,提高了OC中SLN活检的诊断价值.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


